Company intelligence / Profile preview

CardioNXT

Westminster, Colorado, United States

Ownership: Private
Development stage: Other

Overview

CardioNXT has received FDA 510(k) marketing clearance for its iMap 3D Navigation & Mapping System platform (including Activate software, Axis patient patches, and MultiLink sensor-enabled catheter) for use in cardiac arrhythmia procedures, and it is being integrated in preclinical and early clinical studies with multiple pulsed field ablation (PFA) catheters for atrial fibrillation treatment.[1][3][4][5]

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Pulse Biosciences[4][5]Field Medical[4][6]Boston Scientific (Farawave PFA catheter integration)[7]Medtronic (PulseSelect PFA catheter integration)[7]Abbott (Advisor HD Grid Mapping Catheter integration)[7]

Beyond the preview

Go deeper on CardioNXT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardioNXT.

Explore the full profile